Concepedia

I. A. FAVORSKAYA

IA

Statistics

Publications

11

Citations

3.2K

H-Index

10

Active since

2010

Affiliations

Ministry of Health of the Russian Federation(Current)

Russian Cancer Research Center NN Blokhin

Federal Scientific Center of Physical Culture and Sports

27th Central Research Institute of the Ministry of Defence of the Russian Federation

Institute of Bioorganic Chemistry

I. A. FAVORSKAYA is an author at Ministry of Health of the Russian Federation specializing in medicine, virology, and immunology.

ORCID

Top concepts

Publications per year

2010–2023

11

Publications

11

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov et al. · The Lancet · 2021 · 1.8K citations · Full text

, , +10

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov, Inna V. Dolzhikova, Olga V. Zubkova et al. · The Lancet · 2020 · 1.1K citations · Full text

, , +7

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults

Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov et al. · The Lancet Regional Health - Europe · 2021 · 71 citations · Full text

Expression and clinical significance of CRABP1 and CRABP2 in non-small cell lung cancer

I. A. FAVORSKAYA, Yaroslav Kainov, G. Yu. Chemeris et al. · Tumor Biology · 2014 · 41 citations

CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors

Yaroslav Kainov, I. A. FAVORSKAYA, V. V. Delektorskaya et al. · Cell Cycle · 2014 · 35 citations · Full text

1–5 of 11